News

Data has been published showing the success of the IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The device was approved for FDA authorization in April.

Researchers at the Center for BrainHealth® at the University of Texas at Dallas investigated the effects on the brain of concurrent cannabis and nicotine use, versus the use of solely cannabis and solely nicotine.

Beyond the development of life-saving medications and innovative prevention modalities, HIV/AIDS research has led to numerous advances outside the HIV field.

Washington State University researchers have created more than a dozen candidate drugs with the potential to curb smokers' desire for nicotine by slowing how it is broken down in the body.

Researchers at the University of Washington have demonstrated a new technique for mapping the flow of biomolecules in and around solid tumors.

A new study has used artificial intelligence to design an algorithm which can define the level of lymphocyte infiltration into a tumor and provide a predictive score for the efficacy of immunotherapy in the patient.

Scientists have found the primary psychoactive component of marijuana in 63% of breast milk samples for up to six days after the mother’s last reported use.

Researchers reveal a previously unseen 'ecosystem' in advanced breast cancer, in which the primary breast tumor emits signals that halt the growth of secondary tumors elsewhere in the body.

Researchers have deciphered the role of a key protein that the malaria parasite Plasmodium falciparum uses to obtain nutrients while infecting red blood cells.

TREM-1, or triggering receptor expressed on myeloid cells-1, is known to help turn up inflammation short-term to help us deal with external invaders. But scientists now report the first evidence that when activated by chronic offending agents, like obesity and hepatitis, TREM-1 instead contributes to a destructive level of inflammation that results in liver damage and possibly cancer.